Skip to main content

What We Know About Mu, the WHO’s Latest Variant of Interest

The SARS-CoV-2 variant was first detected in January, but its rising prevalence and potential resistance to vaccines has garnered it special attention from the World Health Organization.

Written byChristie Wilcox, PhD
| 2 min read
tube of blood labeled positive for COVID-19 Mu variant

Register for free to listen to this article
Listen with Speechify
0:00
2:00

ABOVE: © ISTOCK.COM, JARUN011

Tthe Mu variant (also known as B.1.621) is the latest form of SARS-CoV-2 to be designated a “Variant of Interest” by the World Health Organization. The agency announced the designation had been made in last week’s epidemiological update, citing an uptick in Mu infections in Ecuador and Colombia, where the variant was first identified in January. In Colombia, it underlies nearly 40 percent of cases, according to WHO data.

According to Public Health England, the variant shares mutations with other variants, most notably the Beta (B.1.351) variant first identified in South Africa. These include the E484K and K417N mutations, which researchers have linked to immune escape. K417N is also seen in the “Delta plus” variant. Additionally, Mu has the P681H mutation seen in the Alpha (B.1.1.7) variant, which is associated with increased transmissibility.

Detailed studies of the Mu variant’s characteristics have yet to be conducted, but ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo